Spain Cancer Diagnostics Market 2013 Sales Forecasts, Supplier Shares, Competitive Strategies

Publisher Name :
Date: 16-Aug-2013
No. of pages: 565

Summary

This comprehensive report contains 565 pages, 85 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the Spanish cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Spanish cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Cancer Diagnostic Tests

ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.

Market Segmentation Analysis


  • Sales and market shares of major suppliers,by individual cancer diagnostic test.

  • Five-year test volume and sales forecasts for major cancer diagnostic tests by market segment, including:

  • Hospitals

  • Commercial/Private Laboratories

  • Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.

  • Cancer statistics, etiology and recent developments.


Current and Emerging Products

  • Review of over 200 current and emerging cancer diagnostic tests,including:

  • Biochemical Markers

  • Oncogenes

  • Growth Factors

  • Hormones

  • Colony Stimulating Factors

  • Lymphokines

  • Immunohistochemical Stains, and others.

  • Analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling prices.


Technology Review

  • Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and other technologies

  • and their potential applications for cancer diagnostic testing.

  • Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy.

  • Extensive listings of over 500 companies, universities and research centers developing new cancer diagnostic tests and detection technologies.


Competitive Assessments

  • Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.


Business Opportunities and Strategic Recommendations

  • Specific new product development opportunities with potentially significant market appeal during the next five years.

  • Design criteria for new products.

  • Alternative market penetration strategies.

  • Potential market entry barriers and risks.

Spain Cancer Diagnostics Market 2013 Sales Forecasts, Supplier Shares, Competitive Strategies

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview
A. Cancer Statistics and Etiology
1. Breast Cancer
2. Lung Cancer
3. Colon and Rectum Cancer
4. Prostate Cancer
5. Stomach Cancer
6. Leukemia
7. Lymphoma
8. Oral Cancer
9. Skin Cancer
10. Uterine Cancer
11. Ovarian Cancer
12. Bladder Cancer
B. Major Current And Emerging Cancer Diagnostic Tests
1. Introduction
2. Tumor Marker Classification
3. ACTH
4. Alpha-Fetoprotein (AFP)
5. Beta-2 Microglobulin
6. CA 15-3/27.29
7. CA 19-9
8. CA-125
9. Calcitonin
10. Carcinoembrionic Antigen (CEA)
11. Estrogen and Progesterone Receptors
12. Ferritin
13. Gastrin
14. Human Chorionic Gonadotropin (HCG)
15. Insulin
16. NSE
17. Occult Blood
18. PAP Smear/HPV
19. Prostatic Acid Phosphatase (PAP)
20. Prostate-Specific Antigen (PSA)
21. Squamous Cell Carcinoma Antigen (SCC)
22. T and B Lymphocytes
23. TdT
24. Thyroglobulin
25. Tissue Polypeptide Antigen (TPA)
26. Biochemical Tumor Markers
ADA
B-Protein
PNP
5'-Nucleotidase
27. Oncogenes
Abl/abl-bcr
AIB1
BCL-2
BRCA1
CD44
C-fos
C-myb
C-myc
CYP-17
Erb-B
HPC1
N-myc
P40
P51
P53
PIK3CA
PTI-1
Ras
Reg
Sis
Src
28. Polypeptide Growth Factors
Basic Fibroblast Growth Factor
Beta-TGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth Factor-Alpha
29. Ectopic Hormones
30. Colony Stimulating Factors
31. Lymphokines
Alpha-Interferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
Gamma-Interferon
Interleukin-1 (IL-1)
Macrophage Activating Factor
32. Immunohistochemical Stains
33. Emerging Tumor Markers
N-Acetylglucosamine
Actin
Alpha-Actin
Antineuronal Antibodies
7B2
B72.3
Bax
BCD-F9
BLCA-4
Blood Group Antigens A,B,H
CA 50
CA 72-4/TAG-72
CA 195
CA-242
CA-549
CAM 26
CAR-3
Cathepsin-D
Chromogranin A and B
Cluster 1 Antigen Cluster-5/5A Antigen CTA
CU18
DR-70
DU-PAN-2
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen Feulgen Hydrolysis
Fibronectin
FSH
(1->3)-L-fucosyltransferase
Gastrin-Releasing Peptide (GRP)
GDCFP-15
Glucagon
Glycoamines
H23
Her-2
Human Carcinoma Antigen HPA
HSP27
Intermediate Filaments
Cytokeratins/CK18/Cyfra 21-1
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA 93
Kinases
KP16D3
LAI
Leukocyte Common Antigen Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma 552
MABDF3
MAG
ME1
Minactivin
MN/CA9
MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor 1
Myosin
NEA-130
NMP22
OA-519
Opiod Peptides
P-glycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative Index, Ki-67
Px
RB Inactivation/Deletion
Ret
SCCL 175
Selectin
Sialic Acid
Sialyl SSEA-1/SLX
SN10
Somatostatin
TA-90
TABA
Tachykinin
TAG 12
TPS
Troponin
Tubulin
VCAM
VEGF
Villen
C. Instrumentation Review And Market Needs
D. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
Overview
ELISA
Immunofiltration
Particle-Membrane Capture Immunoassay
Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
Chemiluminescence
Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
h. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy
G. Personal Testing

III. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers Sales and Market Shares

X. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

XI. Design Criteria for Decentralized Testing Products

XII. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor

XIII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIV. Competitive Profiles
Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Guided Therapeutics
Hologic/Gen-Probe
Kreatech
Kyowa Medex
Life Technologies
Mackay Life Sciences
Myriad Genetics
Nanogen Elitech
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen/Ipsogen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila

XV. Appendixes:
Appendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technology and Applications
Appendix II: Assumed Currency Exchange Rates

List of Tables

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis

Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
Spain, Estimated Cancer Death Rates Per 100,000 Population
Spain, Laboratories Performing Tumor Marker Tests by Market Segment
Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
Spain, Total Tumor Marker Test Volume Forecast by Market Segment
Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
Spain, Total Tumor Marker Sales Forecast by Market Segment
Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecast by Market Segment
Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, S-100 Protein Test Volume And Diagnostics Sales Forecast by Market Segment
Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
Spain, Total Tumor Marker Sales by Major Suppliers
Spain, AFP Testing Market Diagnostics Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
Spain, CEA Testing Market Diagnostics Sales by Major Supplier
Spain, PSA Testing Market Diagnostics Sales by Major Supplier

  • Cancer Diagnostics Markets in China
    Published: 15-Apr-2016        Price: US 4000 Onwards        Pages: 213
    China's demand for Cancer Diagnostics has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, in......
  • Cancer Diagnostics Industry Forecasts - China Focus
    Published: 15-Apr-2016        Price: US 1000 Onwards        Pages: 58
    This study focuses on China's Cancer Diagnostics industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. ......
  • Cancer Diagnostics Companies in China
    Published: 15-Apr-2016        Price: US 1800 Onwards        Pages: 53
    This study focuses on China's Cancer Diagnostics industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions ......
  • North America Solid Tumor Testing Industry 2016 Market Research Report
    Published: 14-Apr-2016        Price: US 3800 Onwards        Pages: 131
    The North America Solid Tumor Testing Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Solid Tumor Testing industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Solid Tumor Testing market analysis is provided for the North America markets including development trends, competitive landscape analysis, and key regions development status.......
  • North America HPV Testing & Pap Test Industry 2016 Market Research Report
    Published: 13-Apr-2016        Price: US 3800 Onwards        Pages: 138
    This is a professional and in-depth study on the current state of the HPV Testing & Pap Test industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The HPV Testing & Pap Test market analysis is provided for the North America markets including development trends, competitive landscape analysis, and key regions dev......
  • North America Prostrate Specific Antigen (PSA) Testing Industry 2016 Market Research Report
    Published: 12-Apr-2016        Price: US 3800 Onwards        Pages: 130
    This is a professional and in-depth study on the current state of the Prostrate Specific Antigen (PSA) Testing industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Prostrate Specific Antigen (PSA) Testing market analysis is provided for the North America markets including development trend......
  • United States Solid Tumor Testing Industry 2016 Market Research Report
    Published: 07-Apr-2016        Price: US 3800 Onwards        Pages: 131
    The United States Solid Tumor Testing Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Solid Tumor Testing industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Solid Tumor Testing market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.......
  • United States HPV Testing & Pap Test Industry 2016 Market Research Report
    Published: 06-Apr-2016        Price: US 3800 Onwards        Pages: 138
    The United States HPV Testing & Pap Test Industry 2016 Market Research Report is a professional and in-depth study on the current state of the HPV Testing & Pap Test industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The HPV Testing & Pap Test market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions developmen......
  • United States Prostrate Specific Antigen (PSA) Testing Industry 2016 Market Research Report
    Published: 05-Apr-2016        Price: US 3800 Onwards        Pages: 130
    This is a professional and in-depth study on the current state of the Prostrate Specific Antigen (PSA) Testing industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Prostrate Specific Antigen (PSA) Testing market analysis is provided for the United States markets including development trend......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs